Meanwhile, a higher mutation ratio of MUC16 in S2 was positive for immune-exhausted genes, such as HAVCR2 and TIGIT. Recent studies have demonstrated that MUC16 mutations are associated with better survival outcomes and immune responses in gastric and endometrial cancers (Wang et al., 2020). The gene discussed is HAVCR2; the disease is endometrial cancer.